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ABSTRACT 
JESSE D. ARBON: Patient Reported Post-operative and Post-discharge Nausea and 
Vomiting following Orthognathic Surgery 
(Under the direction of Dr. Ceib Phillips) 
Postoperative nausea and vomiting (PONV) are common surgical sequelae. PONV 
coincides with physical morbidities and can increase recovery period, delay discharge, and 
lower patient satisfaction.  The purpose of this study was to assess patients’ experience with 
PONV following orthognathic surgery (OS). This prospective observational study enrolled 
60 patients (ages 14-53) between 9/08 and 8/09 prior to OS. Patients completed a daily health 
diary each post-surgical day for 30 days. Data from medical/dental records were obtained to 
assess potential risk factors associated with patients’ PONV experience.  During the first 24 
hours following OS, 58% of patients experienced significant nausea and 47% had an emetic 
event.  30% of subjects continued to report problems with PONV 5 days after being 
discharged.  PONV has a high prevalence among orthognathic surgical patients. PONV 
continues to interfere with patient reported recovery nearly a week following surgery. 
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SECTION I 
LITERATURE REVIEW 
 
No longer do health care practitioners practice in a paternalistic manner.  Patients, 
now more than ever, are actively involved in health care decision making processes.  Thus, it 
is the practitioner’s responsibility to discuss in depth the risks and benefits associated with 
any treatment that may be rendered.  For patients undergoing procedures that require 
anesthesia and surgery, it is equally important that they are well informed of both intra-
operative and postoperative complications.  In the United States alone, more than 71 million 
inpatient and outpatient operative procedures are performed each year.  More than half (40 
million) are reported as inpatient surgical procedures.69 Although medical and 
pharmaceutical advancements have been achieved, postoperative nausea and vomiting 
(PONV) are some of the most frequent and distressing complications following inpatient and 
outpatient surgical procedures.1  Accepted definitions of these factors are: 
• Nausea:  the involuntary sensation or impulse to vomit. 
• Vomit:   to expel the contents of ones stomach through the mouth. 
Anatomy and Physiology 
Although the physiology of the vomiting reflex is well understood, the pathways that 
control nausea and vomiting are not.2 It is currently thought that the act of vomiting, or the 
impulse to do so, is controlled by a vomiting center.  This center is located in the lateral 
reticular formation of the medulla oblongata in the midbrain stem central nervous system.  It 
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is in close proximity to the fourth cerebral ventricle and to the nuclease of the vagus nerve 
(Figure 1).  The area prostrema, which includes the chemoreceptor trigger zone (CTZ) is 
vascular but does not have an effective blood brain barrier.  The area prostrema is laden with 
a variety of receptors including opioid, dopamine, histamine, cholinergic, 5-
hydroxtryptamine (5-HT3) and serotonin.  Many anti-emetics target these receptors and 
antagonize their mechanism of action.  Various pathways can stimulate and activate the 
vomiting center.  The center receives afferent fibers from the periphery (GI tract, 
mediastinum, renal pelvis, peritoneum, genitalia) and from the central nervous system’s 
cortical centers (visual center, vestibular apparatus, and CTZ zone) (Figure 2).3-5  It has been 
and continues to be difficult to systematically and predictably study nausea and vomiting 
given the number of complex receptors and variety of intricate pathways that contribute to its 
occurrence.  
Incidence 
 In 1984 Palazzo and Strunin6 were some of the first to publish a comprehensive 
review of postoperative nausea and vomiting in the Canadian Anaesthetists’ Society Journal.  
In 1992 Watcha and White7 published a more universally recognized review on the etiology, 
treatment and prevention of PONV.  Watcha and colleages comprehensively reviewed data 
from Palazzo’s findings in conjunction with 150 relevant published articles since the 1984 
Palazzo PONV review.  Watcha found, in general, the approximate incidence of PONV 
following surgery varies between 20% and 30%.  This is significantly lower than the 75-80% 
incidence reported during the “ether” era of general anesthesia.7  This same incidence of 20-
30% continues to be reported even in today’s most recent peer reviewed literature.8, 9   
Watcha continued to report that there has been little change in the incidence of PONV since 
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the introduction of halothane in 1956 which widely replaced diethyl ether as a general 
anesthetic.  Thus, Watcha’s findings regarding the general incidence of PONV among the 
surgical population remains unchanged even today.  In spite of significant medical and 
pharmaceutical advancements, little has been done to reduce the overall incidence of PONV 
over the past 54 years for surgical patients undergoing general anesthesia.   
In addition to PONV’s multifactorial nature, it is vitally important to recognize that 
the aforementioned level of incidence for PONV greatly depends on patient’s individual, 
anesthetic and surgical risk factors.6,10,11   
Risk Factors  
Significant advances have been made in the past 20 years on identifying risk factors 
associated with PONV (Table 1).  Although specific risk factors have been identified that are 
generally accepted and supported by sound evidence, mechanisms of PONV are still 
considered a multifactorial problem coupled with complex underlying biology.12   
This review will primarily focus on risk factors that have been studied extensively and are 
widely accepted amongst the medical community as strong indicators for PONV.  These 
include: 
Patient Related 
• Female gender10,13- 20,23 
• History of motion sickness and/or PONV10,13-17,19,20,23-25   
• Non-smoking status10,13-19,27,28 
• Childhood after infancy and younger adulthood25,32,33 
Surgical and Anesthesia Related 
• Use of volatile anesthetics15-17,34-36,39 
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• Duration of anesthesia and/or surgery10,13,15,24,25   
• Postoperative opioids10,13,16,17,18,20,23,24,35,36,,40-43   
Probably the strongest risk factor identified is female gender. Most investigations 
report a significantly lower incidence of nausea and vomiting following surgery in males in 
comparison to females.10,13- 20,23 Some of these studies have demonstrated that women tend to 
experience PONV two to three times more readily than men following surgical procedures.  
It’s important to note that these gender differences are not observed in the prepubescent 
surgical population.16,21  Thus, current theory believes the vomiting center is strongly 
influenced by the individual’s endocrine and hormonal environment.22 
Patients who report a history of PONV and/or motion sickness have also been 
identified as at risk patients for PONV.10,13-17,19,20,23-25  It is thought that patients with a 
history of these factors have established a well developed reflex arc for vomiting.16  Both a 
history of PONV and motion sickness are considered independent predictors for PONV.  
Although some researchers use and study these variables as separate predictors13,23, 
combining the two into one predictive factor has been demonstrated to be a more dependable 
predictor for PONV.10 
Nonsmoking status has been identified as an independent risk factor in a number of 
adult studies assessing PONV.10,13-19,27,28 Odds ratios (OR) for adults with a nonsmoking 
status in these studies have been found to be approximately 1.5 to 2.5.  Two theories exist as 
to why this phenomenon is observed.  Some authors speculate that smoking may have an 
effect on the dopaminergic system thereby diminishing PONV.29  The other and seemingly 
more plausible explanation is that chemicals inhaled through cigarette smoke effect the 
production of certain liver enzymes, especially cytochrome P450.30 The increase in these 
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systemic liver enzymes result in the early metabolism of several ingested or inhaled drugs 
used during anesthesia, thus reducing the incidence of PONV.31 
Generally speaking, increased age is associated with a decreased incidence of PONV.  
Within the pediatric population, postoperative emesis increases with age to reach a peak 
incidence in preadolescents around 11-14 year of age.32  Prepubescent girls apparently lack 
the increased likelihood of PONV which implies that risk, as stated before, relates to certain 
hormonal factors.25,33 
A number of anesthesia related variables have been well established as PONV risk 
factors.  Especially the use of volatile inhalation anesthetics15-17,34-36,39 (isoflurane, 
desflurane, sevoflurane, etc.) which when utilized, the incidence of PONV has been reported 
to occur twice as often when compared to the use of propofol anesthesia alone.36  Due to their 
rapid metabolism, PONV associated with the use of volatile anesthetics usually occurs in the 
first two hours following surgery.16  No significant difference in the risk of PONV has been 
found amongst the aforementioned volatile anesthetic agents.33,36  Total IV anesthesia is a 
possibility and reports a lower incidence of PONV.  However, it is usually restricted to 
shorter surgical procedures (less and 60min) due to the difficulty in maintaining 
normotensive or mildly hypotnesive mean arterial blood pressure.37  Incorporation of a 
volatile inhalation agent, intravenous hypnotics and opioids is thought to be the best 
approach for rapid recovery with a lower incidence of PONV.38,39 
The duration of surgery has also been shown to be an independent risk factor 
associated with PONV.10,13,15,24,25  It has been reported that surgical duration lasting longer 
than 60 minutes increases a patient’s risk of experiencing PONV.  Sinclair et al15 found that 
the prevalence of PONV increased from 2.8% in patients whose surgery was less than 30 
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minutes to 27.7% in patients with a surgical duration of 150-180 minutes.  In summary this 
study indicated that every 30-minute increase in surgical time, resulted in a 60% increase in 
the baseline risk of PONV.15   
 It is well established that the use of intraoperative and perioperative opioids is 
strongly associated with PONV.10,13,16,17,18,20,23,24,35,36,,40-43  Today, opioids are commonly used 
postoperatively for pain management.  Opioids are thought to sensitize otic and vestibular 
areas to motion, resulting in PONV with movement.7,44  Some researchers indicate that 
opiods are seldom the cause of PONV if patients are immobile.45  Short acting opioids (ie, 
fentanyl, remifentanil, sulfentanil) are thought to cause less PONV in comparison to long 
acting opioids (ie, morphine, meperidine).46  For example, morphine is associated with 
stimulation of the CTZ and vestibular apparatus, slowing of gastrointestinal motility, 
prolonged gastric emptying time and increased possibility of esophageal reflux which may 
induce emesis.38,47 
Apfel at al10 when analyzing four of the most widely accepted risk factors (female, hx 
of PONV/motionsickness, nonsmokers, postoperative opioids) found that the incidence of 
PONV was 10-21% in patients with no more than 1 risk factor.  When two factors were 
present, the incidence rose to 39%.  When three and four factors were identified for the same 
surgical patient, the incidence of PONV was reported to be 61% and 79% respectively.  
These findings have been further supported by two additional reports studying an inpatient 
surgical population.12,55 
Type of Surgery 
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 A number of studies have evaluated the incidence of PONV related to the type of 
surgery performed.  Although there is some conflicting evidence, it is generally accepted that 
certain procedures carry an increased risk for PONV.14-17,,35,41,48  These procedures include: 
• Ear, nose and throat (ENT)13,15,17-19,34,35,36,49 
• Gynecological13,15-19,25,28,35,36 
• Opthalmologic13,15,17-20,25,34,36,50,51,52,53 
• Neurosurgery12,13,15,17,18,19,28,34,36,49,52 
• Laparoscopic12,13,15,17,18,19,28,34,36,49,52,54 
• Intra-abdominal12,13,15,17,18,19,28,34,36,49,52,54 
Among the above surgeries, the highest incidences of PONV have been reported at 
80% for ophthalmaologic, 70% for ENT, 40-70% for intra-abdominal and 40-77% for 
laparoscopic surgeries. 13,15,17-20,25,34,36 Apfel et al.10 found that type of surgery was not an 
independent risk factor for predicting PONV.  When Apfel controlled for other risk factors, 
type of anesthetic and duration of operation, a causal effect on PONV by type of operation 
could not be established.  These findings were all based on inpatient surgical cases.  However 
in a large study of 18,000 ambulatory patients Sinclair et al15 showed an increased risk for 
PONV (>15%) among patients undergoing dental surgery, orthopedic shoulder procedures, 
gynecologic laparoscopy, breast augmentation and strabismus repair.   
The big little problem55 
 In 1991 Kapur described perioperative nausea and vomiting as “the big little 
problem” following ambulatory surgery.55 Even though PONV is self-limiting and not fatal56 
it can result in significant morbidity.  The undesirable sequela of PONV include dehydration, 
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electrolyte imbalance, suture tension and dehiscence, venous hypertension and bleeding, 
esophageal rupture, and life threatening airway compromise.36,57 
 Macario et al58 utilized a preoperative survey and reported that patients ranked emesis 
as the most undesirable and nausea as the fourth most undesirable anticipated negative 
postoperative outcome.  In this study gagging on the tracheal tube ranked second and pain 
ranked third.  In another study examining patients’ perception of PONV Gan et al59 found 
that patients were, on average, willing to pay $56 out-of-pocket to avoid PONV; this dollar 
amount increased to $73 for patient who had experience postoperative nausea and to $100 in 
patients who had experienced postoperative vomiting.  Studies have also suggested that not 
only do patients rank the absence of PONV as important but also rank it higher in importance 
than earlier discharge from outpatient surgical units.58,60 PONV has also been shown to 
extend the recovery period, delay discharge, increase medical costs, and lower patient 
satisfaction scores.7,62,63PONV is clearly unsettling and creates considerable anxiety for both 
the recovering patient and his/her caregiver. 
Post Discharge Nausea and Vomiting 
 
 Significant research associated with PONV it’s risk factors and prevention has been 
performed in the last 20 years.  It is important to note the majority of studies focus on the 
short-term incidence of PONV, meaning the first postoperative 24 hours.  Furthermore, some 
patients experience PONV for the first time after discharge.67 This distinguishment is 
important given the fact that as many as 35% - 50% of patients will experience post-
discharge nausea and vomiting (PDNV).63,64  However, very few studies have focused on and 
examined PDNV.  Carroll et al63 reported that patients with post-discharge nausea and 
vomiting require a longer time to resume normal daily activities.  Carroll also reported that 
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nausea and vomiting in the immediate postoperative period may not accurately predict the 
incidence of nausea and vomiting after discharge from the hospital.63  Wu et al14 in 2002 
published the first systematic review dedicated to post-discharge symptoms which included a 
thorough investigation of PDNV.  This report indicated an incidence of 17% for nausea 
(range 0-55%) and 8% for vomiting (0-16%) after outpatient surgery.  Philip et al65 in a 
prospective multicenter survey reported even higher incidences of nausea and vomiting 
following ambulatory  surgery.  Nausea occurred in 46% of patients on postoperative day 1 
and 8% on postoperative day 7.  Vomiting occurred in 12% of patients on postoperative day 
1 and 1% on postoperative day 7.  Interestingly, nearly half the patients who did not have 
PONV in the hospital experienced nausea and/or vomiting on post-discharge days 1-3.65 
Gupta et al66 examined published randomized, controlled trials to investigate whether routine 
antiemetic prophylaxis reduces the incidence of PDNV after ambulatory surgery in adults.  
Their comprehensive review reported a total of 815 patients who experienced post-discharge 
nausea(PDN) (32.6%). The number of patients who had PDN in the placebo and treatment 
groups were 276 (35.7%) and 539 (31.2%), respectively.  Also reported in this review was a 
total of 497 patients who experienced post-discharge vomiting (PDV) (14.7%). In the 
placebo group, 19.6% of patients had PDV, whereas 12.1% of those in the treated group had 
PDV.66   
Orthognathic Surgery 
According to the American association of Oral and Maxillofacial Surgeons, 
“Corrective jaw, or orthognathic, surgery is performed by Oral and Maxillofacial Surgeons to 
correct a wide range of minor and major skeletal and dental irregularities, including the 
misalignment of jaws and teeth, which, in turn, can improve chewing, speaking and 
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breathing. While the patient's appearance may be dramatically enhanced as a result of their 
surgery, orthognathic surgery is performed to correct functional problems.” 
 The first reported incidence of PONV in an orthognathic surgical population is 
reported in William R. Proffit’s text book entitled “Contemporary Treatment of Dentofacial 
Deformity”.  In the final chapter on prevention and management of orthognathic surgical 
complications, page 695, Proffit reports that an unpublished review of 1000 consecutive 
orthognathic surgical cases was performed by Dr. Myron Tucker, a full time faculty member 
at the University of North Carolina School of Dentistry and UNC Hospitals from 1982 to 
1992 where he was the director of graduate education in oral and maxillofacial surgery.  
Tucker found that 40% of his postoperative patients had at least one episode of nausea and/or 
vomiting.  He further concluded that nausea due to swallowed blood was more common in 
two-jaw surgery because of increased hemmorage.68 
 Currently only one published study exists9 that has reported the incidence of PONV in 
a sample of orthognathic sugery patients.  Silva et al9 conducted a retrospective cross-
sectional survey of 553 consecutively treated patients over the age of 14.  The patients 
underwent maxillary and/or mandibular osteotomies at Kaiser Permanente Hospital in 
Oakland, California between January 2003 to March 2004.  Of the 514 patients that met the 
studies criteria, 40.08% experienced PONV during the first 24 hours after surgery.  This 
retrospective analysis based the  incidence of PONV on nursing notes made in the 
postanesthesia recovery room and the short-stay units while the patient was in the hospital.  
Silva et al9 also analyzed risk factors that were associated with patients’ that experienced 
PONV.  They concluded that the most important predictive factors were female gender, 
young patients (15 to 25 years old), nonsmoking status, prior history of PONV/motion 
  
11 
sickness, use of volatile general anesthetics, maxillary surgery, postoperative pain level and 
the use of postoperative analgesic opioids.  In addition they found a direct proportional 
relationship between the number of risk factors and the prevalence of PONV.  Demonstrating 
that patient’s reporting any 4 of the above risk factors was 58.8% more likely to experience 
PONV.9 
In the current body of literature, there is no patient reported prospective 
documentation of PONV, let alone PDNV, following orthognathic surgery.   
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SECTION II 
MANUSCRIPT 
INTRODUCTION  
In the United States more than 71 million inpatient and outpatient surgical procedures 
are performed each year.1  In the U.S. and in spite of significant medical and pharmaceutical 
advancements, post-operative nausea and vomiting (PONV) remain as frequent and 
distressing post-operative complications following inpatient and outpatient surgical 
procedures.2   
Patients who have experienced PONV testify to its disturbing and unsettling nature.  
Patients have reported that PONV is a greater concern than that of post-operative pain.3  In 
addition, patients who experienced PONV were willing to spend up to $100 dollars out of 
pocket for an effective antiemetic.4  Studies suggest that not only do patients rank the 
absence of PONV as important but also rank it higher in importance than earlydischarge.3,5  
In addition to the acute episode of PONV, sequela include aspiration, deyhydration, 
electrolyte imbalances, gastric bleeding, hematoma, increased intracranial pressure, need to 
release intermaxillary fixation, pulmonary edema, and possible death.6,7  PONV has also 
been shown to extend the recovery period, delay discharge, increase medical costs, and lower 
patient satisfaction.6,8,9   
In general, it has been estimated that 20% to 30% of all patients experience PONV as 
a complication of surgery and anesthesia.6,10,11,12  However the incidence greatly depends on 
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the patient’s individual, anesthesia and surgical risk factors.13,14,15  For instance, the 
frequency of PONV for patients with previously studied risk factors (female, history of 
motion sickness and/or PONV, nonsmoking status, use of post-operative opioids) in certain 
high risk procedures like ophthalmologic surgery, have been reported as high as 70-
80%.14,16,17  In addition, 30% to 50% of patients treated on an outpatient basis continue to 
experience post-discharge nausea and vomiting (PDNV).9,18  
In a retrospective medical chart analysis, Silva et al.19 reported 40% of patients who 
underwent orthognathic surgery experienced PONV during the first 24 hours following 
surgery.  Estimates regarding the incidence of post-discharge nausea and vomiting (PDNV) 
are not currently available for orthognathic surgical patients.   Understanding PONV and 
PDNV are  particularly important when surgery is performed in an ambulatory care setting 
requiring patients to cope with post-operative sequela in the absence of direct medical 
supervision; resulting in considerable anxiety for both the recovering patient and his/her 
caregiver.18 The purpose of this study was to prospectively assess the patient reported 
incidence, severity, duration, and risk factors associated with PONV and PDNV following 
orthognathic surgery.   
MATERIALS AND METHODS 
Sixty subjects, 14 years old and older, scheduled for an orthognathic surgical 
procedure for the correction of a dentofacial developmental disharmony or severe 
malocclusion between September 2008 and May 2009 at the University of North Carolina 
Memorial Hospital consented to participate in this prospective clinical study. Subjects were 
not excluded on the basis of sex or race.  Subjects were excluded if they displayed one or 
more of the following attributes: congenital anomaly or history of acute facial trauma; 
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previous facial surgery; a medical condition associated with neuropathy (diabetes, 
hypertension, kidney problems); inability to follow written English instructions; unwilling to 
sign informed consent.  The project was approved by the Biomedical Institutional Review 
Board. 
A research associate described the project to each subject and obtained written 
consent or assent with parental permission and HIPPA authorization to review clinical 
records.   All patients had undergone orthodontic preparation for orthognathic surgery and 
presented with fixed orthodontic appliances at the time of surgery.  All orthognathic surgical 
procedures were performed by oral and maxillofacial surgery faculty and residents at N.C. 
Memorial Hospital.  Semi- rigid fixation was utilized to stabilize bony jaw segments in 
conjuction with interocclusal wafers.  
Accepted definitions in this study regarding PONV and PDNV are: 
1. PONV: Post-operative nausea and vomiting while the patient was in the hospital 
(approximately 24 hours from surgical completion) 
2. PDNV: Post-discharge nausea and vomiting starting from the time each patient was 
dismissed from the hospital. 
Potential pre-, intra- and post-operative risk factors known to contribute to post-
operative nausea and vomiting (PONV) were abstracted from each subject’s medical chart.  
Preoperative data included demographic and health history variables; intra-operative data 
included surgical, anesthesia and pharmaceutical variables; post-operative data encompassed 
post-surgical medications and surgical/nursing notes to determine subjects’ experience with 
PONV while in the hospital. Table 1 displays a more complete list of data gathered from 
medical charts. 
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A post-orthognathic surgical daily health diary (OSPostop) was modified to include 
specific items relating to nausea and emesis.20,21 Subjects were asked to complete the diary 
each post-surgery day for 30 days.  Nausea was rated on a 5 point scale from No 
Trouble/Concern (1) to Lots of Trouble/Concern (5).  Subjects were also asked to report the 
presence/absence of emesis while in the hospital and each post-surgical day during the 
recovery period.  Additionally, subjects were requested to record whether medications were 
taken for pain/discomfort and if so, what medications were taken and at what dose. 
Subjects returned for routine post-operative visits with the surgical attending at one 
and four weeks.  Subjects were asked to bring their completed diaries to these visits.  If 
subjects failed to comply, a research associate provided the subject with pre-addressed and 
pre-metered envelopes to facilitate the diary return by mail. 
Within the medical record: Inpatient progress notes, general progress notes, clinic 
note reports and discharge summary reports were evaluated to determine post-operative 
nausea.  Reports for post-discharge nausea were stratified into two categories.  Those scoring 
a 1 or 2 on the health diary each day were categorized as “No Substantial Interference”; 
while those scoring 3,4 or 5 were designated as having “Substantial Interference” with 
nausea.  Additional data from medical charts were collected to evaluate potential risk factors 
associated with PONV (Table 2). 
Data regarding post-operative and post-discharge vomiting were obtained from the 
OSPostop.  Where patients reported presence/absence of emesis while in the hospital and 
each post-surgical day during the recovery period.   
RESULTS 
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60 subjects consented to participate in this prospective observational study prior to 
orthognathic surgery.  Seven subjects were dropped due to cancellation of their surgical 
procedure (insurance denied coverage, patient decided against surgery).  Of the remaining 53 
subjects, 39 (73%) completed and returned all 30 days of the recovery health diary.  1 patient 
had incomplete hospital records missing data required for this study  (Figure 3). 
Patients who participated were primarily female (68%) and Caucasion (63%).     
Subjects ranged in age from 15 to 48 years (median = 21 years; IQR = 17-27 years).  
Subjects were generally healthy and without systemic diseases (97% reported an ASA 
classification of 1 or 2).  37% had a procedure involving both jaws, 26% had a maxillary 
only procedure and 37% had a mandibular only procedure.  See Table 3. 
Medications 
Evaluation of medical records (anesthesia, medication administration and post-
anesthesia care records) revealed an extensive variety of administered medications.  Peri- and 
intra-operatively greater than 90% of subjects received: benzodiazepines, local anesthetics, 
corticosteroids, short acting opioids (fentanyl), hypnotic, and antiemetics.  All subjects 
received at least one or a two drug combination of volatile anesthetics and neuromuscular 
blocking agents.  During the post-operative recovery period while in the hospital, greater 
than 90% were prescribed short acting opioids and antihistamines.  Record analysis indicated 
a lack of specific protocols and inconsistencies in medical records regarding medications 
administered.  The information available in the medical records was too vague and variable 
for statistical analysis. 
PONV and PDNV 
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58% of subjects experienced nausea and 47% reported an emetic event while in the 
hospital (Figure 4).  Forty-five percent of the subjects experienced nausea and 21% reported 
an emetic event after being released from the hospital (Figure 5). 
29% of those who reported problems with post-discharge nausea did not have an 
emetic event while in the hospital.  Three subjects (8%) reported experiencing nausea for the 
first time following discharge.  Just over half (59%) of the subjects with post-discharge 
nausea reported no problems by day 3 after surgery.  5 patients (13%) reported problems with 
nausea up until the 5th postsurgical day (Figure 6). 
Of the 18 patients who experienced emesis in the hospital, 8 (44%) had an additional 
emetic event following discharge.  All patients who reported post-discharge vomiting had an 
emetic event and reported being nauseous in the hospital. Most (95%) patients reported 
complete resolution of vomiting by day 2 after surgery.  Two patients reported emesis up 
until the 4th and 6th postsurgical day (Figure 6). 
Relationship between Potential Risk Factors and PONV/PDNV 
 
 Simple cross-tabulations of potential risk factors and  the occurrence of nausea and 
vomiting during the patients’ hospital stay (PONV) are reported in Table 4 and post-
discharge (PDNV) in Table 5.  Patients’ who indicated taking an opioid (oxycodone, 
hydrocodone or any medication with codeine) for pain management in their recovery diary 
on the first day following discharge were given a positive response for “patient reported 
opioid Rx”.   
 Patient characteristics:  In this sample males were more likely to experience PONV 
than females (Table 4).  However, after discharge (Table 5) the proportion of males and 
females reporting PDNV was approximately the same.  Teenage patients had an increased 
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likelihood compared to patients 20 years and older of PONV (Table 4) but not PDNV (Table 
5).  Subjects with a positive history of PONV and/or motion sickness were more likely to 
experience post-discharge nausea than post-discharge emesis.  The previous history of 
PONV/motion sickenss did not appear to affect PONV. 
Intra/post-operative characteristics:  Patients undergoing a procedure involving 
maxillary surgery had an increased trend for both PONV and PDNV.  Patients also had a 
strong likelihood of PONV with the administration of intra-operative nitrous oxide.  
Increased anesthesia time (≥ 180 minutes) appeared to increase the likelihood of patients 
experiencing post-operative nausea but not post-operative emesis or PDNV.  The 
administration of post-operative long acting opioids (meperidine and/or morphine) appeared 
to be a strong indicator for patients experiencing PONV and post-discharge nausea.  
Likewise, patients who reported taking opioids after discharge seemed much more likely to 
experience PDNV. 
DISCUSSION 
Post-operative nausea and vomiting 
Our study found a high incidence of PONV following orthognathic surgery.  58% of 
all subjects experienced nausea and 47% reported at least one emetic event while in the 
hospital.  In 1992 Watcha et al6 found the approximate incidence of PONV following surgery 
varies between 20% and 30%.  This same level of incidence (20-30%) continues to be 
reported even in today’s most recent peer reviewed literature.10,19   Although there is some 
conflicting evidence, it is generally accepted that the risk for PONV is influenced by type of 
surgery.  Ear, nose and throat (ENT), ophthalmologic, neurosurgery, gynecologic, 
laparoscopic and intra-abdominal surgeries have been identified as conduit procedures 
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increasing the risk for PONV.22,25-30    Some of the highest incidences are reported at 80% for 
ophthalmaologic, 70% for ENT, 40-70% for intra-abdominal and 40-77% for laparoscopic 
surgeries. 7,12,26,28,31-35 Given the results of this study, orthognathic surgery should be regarded 
as a high risk procedure for PONV. 
One published study has reported the incidence of PONV in a sample of orthognathic 
surgery patients.  In a sample of 515 patients, Silva et al19 found 40.1% experienced PONV 
during the first 24 hours after surgery.  This level of incidence coincides with an unpublished 
review by Dr. Myron Tucker of 1000 consecutive orthognathic surgical cases at the 
University of North Carolina School of dentistry.24  Differing levels of incidence in the 
aforementioned studies to our study may reflect dissimilarity in study design.  Both Silva and 
Tucker performed retrospective analyses of patients’ medical charts.  In addition, both 
reviews combined nausea and vomiting as a single event as opposed to analyzing them 
separately.  Our study prospectively analyzed patient reported experiences with both nausea 
and vomiting, but due to time requirements, cost, etc. associated with prospective 
longitudinal studies, our sample size was drastically smaller.  Certainly more studies should 
be undertaken analyzing the relationship and differences between nausea and vomiting as 
two differing phenomena. 
Post-discharge nausea and vomiting 
 Similar to PONV, we found a high incidence of PDNV was found with 44% of 
patients reported significant nausea and 21% reported at least one emetic event following 
discharge from the hospital.  Gupta et al36 examined PDNV after ambulatory surgery in 
adults and reported an incidence of 32.6% and 14.7% for post-discharge nausea and vomiting 
respectively.  It is important to note the majority of studies analyze the short-term incidence 
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of PONV, meaning the first post-operative 24 hours.  Furthermore, some patients experience 
PONV for the first time after discharge.37 Few studies have focused on and examined PDNV, 
an important issue because even with the limited available data, as many as 35% - 50% of 
surgical patients will potentially experience PDNV.9,18   
In our sample, 29% of those who reported problems with nausea after discharge did 
not have an emetic event while in the hospital, and 3 patients (8%) reported experiencing 
nausea for the first time following hospital discharge.  Carrol et al.9 reported that nausea and 
vomiting in the immediate post-operative period may not accurately predict the incidence of 
PDNV.  Our data support this finding, although, in our sample, all patients who reported 
post-discharge vomiting had an emetic event and reported being nauseous in the hospital.   
All subjects in our sample reached a full recovery within one week following surgery.    
Just over half (59%) of our subjects with post-discharge nausea reported no nausea and 
vomiting by day 3 after surgery.  5 (13%) patients reported problems with nausea up until the 
5th postsurgical day.  Most (95%) patients reported complete resolution of vomiting by day 2 
after surgery.  Two patients reported emesis up until the 4th and 6th postsurgical day.  By the 
7th postsurgical day all patients in our sample reported complete recovery from PDNV.  
Similarly, Philip and colleagues38 also reported nausea occurred in 46% of patients on post-
operative day 1 and 8% on post-operative day 7.  Vomiting occurred in 12% of patients on 
post-operative day 1 and 1% on post-operative day 7.38   
For patients undergoing procedures that require anesthesia and surgery, it is important 
that they are well informed of both intra-operative and post-operative complications.  Since 
the 1980’s, a gradual shift from inpatient surgical procedures to ambulatory surgery has 
occurred.  This trend has continued even further and currently we see a shift in location from 
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an ambulatory setting to office-based surgical procedures involving anesthesia.23  The 
Society of Ambulatory Surgery (SAMBA) currently reports 65% of all surgical procedures 
are now done on an outpatient basis.23  Orthognathic surgery in many locations has mirrored 
such trends.  As surgeons perfect techniques, technology continues to progress, health care 
costs continue to rise and patient and practitioner desires for convenience flourish; we 
suspect office-based orthognathic surgery will only increase in relation to inpatient surgery.  
Now more than ever, patients and practitioners need to understand the intricate aspects of 
surgical recovery; especially for patients who are required to cope with post-operative 
sequela, including PONV/PDNV, in the absence of direct medical supervision. 
Potential risk factors 
 Potential risk factors evaluated in our study included: Female gender, age, history of 
PONV and/or motion sickness, type of surgery, use of intra-operative nitrous oxide, large 
intra-operative doses of neostigmine (≥ 2.5mg), post-operative long acting opioids and 
duration of anesthesia, all of which have been studied extensively and are widely accepted as 
strong indicators for PONV.22   Although nonsmoking status and the use of volatile 
anesthetics are well established independent risk factors, these variables were not analyzed 
given that all 38 subjects received a volatile anesthetic during surgery and more than 90% 
reported they were non-smokers. 
Due to the number of potential risk factors and sample size, we were not able to 
perform statistical analyses with sufficient power to demonstrate significance regarding risk 
factors and PONV/PDNV.  Therefore descriptive statistics were performed and recorded in 
tables 3 and 4.  Plausible trends in our sample for PONV were identified that are congruent 
with current evidence based literature. 
  
28  
PONV potential risk factors in our study supported by literature 
Our teenage patients (< 20yrs old) demonstrated an increased likelihood of nausea, 
reporting an incidence of 65% compared to patients 20 years and older reporting a 52% 
incidence.  Likewise, 53% of teenage patients reported an emetic event compared to 44% of 
patients 20 years and older.  Increased age has been associated with a decreased incidence of 
PONV.  Within the pediatric population, post-operative emesis increases with age to reach a 
peak incidence in preadolescents around 11-14 year of age.39  Prepubescent girls apparently 
lack the increased likelihood of PONV which implies that risk may relate to certain hormonal 
factors.34,40 
 Maxillary only or 2 jaw procedures demonstrated a trend in the likelihood of PONV 
with 63% experiencing nausea compared to 50% who underwent mandibular surgery only.  
Emetic events in patients where the maxilla was involved reported a 54% incidence 
compared to 36% who did not.  Silva et al19 reported a statistically significant correlation 
with PONV when the maxilla was involved in the surgery. 
 Patients demonstrated increased nausea and vomiting when intra-operative nitrous 
oxide was used.  69% and 62% of patient administered nitrous oxide experienced nausea and 
vomiting respectively, compared to 31% who experienced nausea and 40%  who reported 
emesis but were not prescribed intra-operative nitrous oxide.  Administration of nitrous oxide 
is an established risk factor for PONV with incidence levels ranging from 49% - 67%.35,40-44   
Patients who were administered post-operative long acting opioids (meperidine 
and/or morphine) appeared more likely to report nausea and vomiting recording an incidence 
of 62% and 52% respectively.  While those who were not administered long acting opioids 
reported an incidence of 43% for nausea and 29% for emesis. It is well established that the 
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use of intra-operative and perioperative opioids is strongly associated with PONV.12,14,21,22,27-
29,31,33,44-47 
 Opioids are thought to sensitize otic and vestibular areas to motion, resulting in 
PONV with movement.6,48  Short acting opioids (ie, fentanyl, remifentanil, sulfentanil) are 
thought to cause less PONV in comparison to long acting opioids (eg, morphine, 
meperidine).49  Morphine is associated with stimulation of the chemoreceptor trigger zone 
(CTZ) and vestibular apparatus which may induce emesis.50,51 
Increased anesthesia time (≥ 180 minutes) appeared to increase the percent of patients 
experiencing PONV.  65% of patients with a total anesthesia time greater than 180 minutes 
experienced nausea while 50% with less than 180 total anesthesia time reported nausea.  The 
duration of surgery has also been shown to be an independent risk factor associated with 
PONV.14,26,31,34,44  It has been reported that surgical duration lasting longer than 60 minutes 
increases a patient’s risk of experiencing PONV.  Sinclair et al26 found that the prevalence of 
PONV increased from 2.8% in patients whose surgery was less than 30 minutes to 27.7% in 
patients with a surgical duration of 150-180 minutes.  Stated slightly differently, Sinclair 
indicated that every 30-minute increase in surgical time, resulted in a 60% increase in the 
baseline risk of PONV.26   
PONV trends unique to this study 
Our study did not demonstrate that female gender was a strong indicator for PONV 
when in fact it is probably the strongest risk factor identified in the literature. Most 
investigations report a significantly lower incidence of nausea and vomiting following 
surgery in males in comparison to females.12,14,25-28,31-33,52 Some studies have quantified that 
women tend to experience PONV two to three times more readily than men following 
surgical procedures.  It’s important to note that these gender differences are not observed in 
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the prepubescent surgical population.27,53  Thus, current theory believes the vomiting center 
is strongly influenced by the individual’s endocrine and hormonal environment.54 The risk 
with small sample sizes is that the sample may not be a true representation of the desired 
surgical population.  However, given that this is the first prospective observation of 
PONV/PDNV for orthognathic surgical patients, the high incidence of PONV for males 
should not be discounted and commands further investigation. 
Likewise, for subjects with a positive history of PONV and/or motion sickness, our 
sample did not demonstrate increase PONV. History of PONV and/or motion sickness has 
also been identified placing a patient at risk for PONV. 14,31,25-28,32,33,34,44,52  It is thought that 
patients with a history of these factors have established a well developed reflex arc for 
vomiting.27  Both a history of PONV and motion sickness are considered independent 
predictors for PONV.  However combining the two into one predictive factor has been 
demonstrated to be a more dependable predictor.14 In this study, these data were gathered 
from medical charts.  Retrospectively gathering data on such forms assumes with certainty 
that physicians asked the appropriate health history questions and recorded them correctly.  It 
is possible that this data was incomplete and did not reflect the samples absolute response to 
inquiries related to health history. 
Potential post-discharge nausea and vomiting risk factors 
 With a limited number of studies evaluating PDNV; strong prospective indicators for 
PDNV have not been well established.  It has been advocated by some that PDNV carries 
similar risk factors to PONV including: female gender, young age, history of PONV and/or 
PONV in the PACU, and perioperative opioids.23 Data from our study does coincide with 
some of the aforementioned suggested risk factors.  In our sample patients reporting a history 
  
31  
of PONVand/or motion sickness portraid and increase in the likelihood of post-discharge 
nausea.  83% of those with a positive history for PONV and/or motion sickness reported 
experiencing nausea after discharge.  48% of patients who received long acting opioids also 
reported post-discharge nausea compared to 29% who did not receive long acting opioids.  
Patients who took opioids after discharge seemed much more likely to experience post-
discharge nausea and vomiting reporting incidences of 58% and 25% respectively.  Minimal 
data is available for PDNV.  The high incidence in our study and others warrants more 
studies with a primary focus on PDNV to determine its incidence, duration, relationship to 
PONV and potential risk factors. 
Although our understanding of risk factors associated with PONV his increased 
dramatically over the past 30 years, reduction of its occurrence has not significantly 
improved. The incidence for post-operative nausea and vomiting in orthognathic surgical 
patients is high.  PONV and PDNV continues to plaque orthognathic surgical patient 
recovery up to a week following hospital discharge.  Now more than ever, patients and 
practitioners need to understand the intricate aspects of surgical recovery; especially for 
patients who are required to cope with post-operative sequela, including PONV/PDNV, in 
the absence of direct medical supervision.   
CONCLUSIONS 
• The incidence of PONV in orthognathic surgical patients remains high.  
• The incidence of PDNV appears to be greater than 20% 
• The occurrence of PONV/PDNV can cause discomfort up to a week following 
orthognathic surgery. 
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• Surgical procedures involving a maxillary osteotomy appear to increase the likelihood 
of PONV and PDNV.  
• Patients who were administered long-acting and post-operative opioids appear more 
likely to experience PONV and PDNV.  
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Figure 1.  Anatomical relationships of the brain involved with nausea and 
vomitingwww.nauseaandvomiting.co.uk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Mechanisms and neurotransmitter pathways of PONVSilva et al, 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Preoperative Characteristics
Age
Gender
Race
     Caucasian vs. Non-Caucasian
Body Mass Index
     Underweight (BMI <18.5)
     Normal weight (BMI <18.5-24.9)
     Overweight (25-29.9)
     Obese (30 or greater)
Mallampati Score
     I, II, II or IV
American Society of 
Anesthesia Status
     I, II, II or IV
History of PONV
History of Motion Sickness
History of GERD
60subjects
Initially Recruited
7 subjects
Cancelled Surgery
(insurance, pt desires, etc.)
Table 1.  Risk factors for postoperative nausea and vomiting
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Potential preoperative, intraoperative
PONV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Subject Selection Flow Chart
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Intraoperative Characteristics
Type of Surgery
     Mandibular only
     Maxillary only
     Bimaxillary (2J)
Additional Procedures
     Extraction of 2 or more 3rd molars
     Genioplasty
Anesthesia duration
Surgical duration (incision to dressing)
Intraoperative medications
     ex: opioids, neuromuscular blockers
     (NMB), NMB reversal agents,
     antiemetics, hypnotic, nitrous oxide,
     volatile anesthetics, etc.
Blood loss
Postoperative Characteristics
Post-op meds administered in hospital
     ex: long acting opioids(morpine &
     meperidine), antiemetics, etc.
Surgeon/Nursing notes 
     Relating to PONV
53 subjects
Remaining
14 subjects
Didn’t complete diary
(incomplete diary, didn’t want
to continue participating)
39 subjects
Final Sample Size
1 subject
Had incomplete 
medical records
 Apfel et al. 2003
 
 and postoperative risk factors for 
 
  
39  
N %
Female 26 68
Male 12 32
Caucasian 24 63
Other 14 37
Age
Teenager (14-19) 17 45
Twenties 13 34
Thirties 5 13
Forty and over (40-48) 3 8
Type of Sx
Two Jaw 14 37
Maxilla only 10 26
Mandible only 14 37
Demographic and Surgical Characteristics
PO
N
V
 
in
 
H
o
sp
ita
l %
No            Yes No            Yes
47.4%
52.6%
42.1%
57.9%
Patient Reported PONV while in the Hospital
Table 3.  
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No            Yes No            Yes
21.1%
78.9%
55.3%
44.7%
Patient Reported Post Discharge Nausea and Vomiting
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Postsurgical Days
(PACU=Post Anesthesia Care Unit)
Figure 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.   Patient reported PONV & PDNV following orthognathic surgery 
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No Yes No Yes
Gender
Female 46.1% 53.9% 61.5% 38.5%
Male 33.3% 66.7% 33.3% 66.7%
Age
< 20 yrs old 35.4% 64.7% 47.1% 52.9%
≥ 21 yrs old 47.6% 52.4% 57.1% 42.9%
Hx of PONV/
Mot. Sickness No 41.9% 58.1% 54.8% 45.2%
Yes 50.0% 50.0% 50.0% 50.0%
Type of 
Surgery Mand only 50.0% 50.0% 64.3% 35.7%
Mx or 2 jaw 37.5% 62.5% 45.8% 54.2%
Intra-op
Nitrous Oxide No 48.0% 30.8% 60.0% 40.0%
Yes 52.0% 69.2% 38.5% 61.5%
Intra-op
neostigmine < 2.5 34.6% 65.4% 50.0% 50.0%
≥ 2.5 58.3% 41.7% 58.3% 41.7%
Post-op long 
acting opioids No 57.1% 42.9% 71.4% 28.6%
Yes 38.7% 62.3% 48.4% 51.6%
Duration of 
anesthesia < 180 min 50.0% 50.0% 55.6% 44.4%
≥ 181 min 35.0% 65.0% 50.0% 50.0%
Nausea Vomiting
Potential Risk Factors
Table 4.  Potential Risk Factors and PONV while in Hospital 
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No Yes No Yes
Gender
Female 54% 46% 81% 19%
Male 58% 42% 75% 25%
Age
< 20 yrs old 59% 41% 76% 24%
≥ 21 yrs old 52% 48% 81% 19%
Hx of PONV/
Mot. Sickness No 61% 39% 81% 19%
Yes 17% 83% 83% 17%
Type of 
Surgery Mand only 64% 36% 93% 7%
Mx or 2 jaw 50% 50% 71% 29%
Duration of 
anesthesia < 180 min 50% 50% 83% 17%
≥ 181 min 60% 40% 75% 25%
Post-op long 
acting opioids No 71% 29% 86% 14%
Yes 52% 48% 77% 23%
Pt reported 
opioid Rx No 80% 20% 100% 0%
Yes 42% 58% 75% 25%
PD Nausea PD Vomiting
Potential Risk Factors
Potential Risk Factors and PDNV
 
 
Table 5.  
